Clinico-pathological outcomes after total parietal peritonectomy, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced serous papillary peritoneal carcinoma submitted to neoadjuvant systemic chemotherapy- largest single institute experience. [electronic resource]
Producer: 20200618Description: 2103-2108 p. digitalISSN:- 1532-2157
- Adenocarcinoma, Papillary -- pathology
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carboplatin -- administration & dosage
- Cisplatin -- administration & dosage
- Cytoreduction Surgical Procedures
- Doxorubicin -- administration & dosage
- Female
- Humans
- Hyperthermia, Induced
- Infusions, Parenteral
- Length of Stay
- Middle Aged
- Neoadjuvant Therapy
- Neoplasms, Cystic, Mucinous, and Serous -- pathology
- Paclitaxel -- administration & dosage
- Peritoneal Neoplasms -- pathology
- Peritoneum -- surgery
- Postoperative Complications -- epidemiology
- Progression-Free Survival
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.